In Vitro Antimicrobial Activity of Doripenem, a New Carbapenem

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 4, 2004, Pages 1384-1396

  Ge, Yigong ^a   Wikler, Matthew A ^a   Sahm, Daniel F ^b   Blosser Middleton, Renée S ^b   Karlowsky, James A ^b  

^a Peninsula Pharmaceuticals   (United States)

^b Focus Technologies Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; DORIPENEM; ERTAPENEM; IMIPENEM; MEROPENEM; OXACILLIN; PIPERACILLIN PLUS TAZOBACTAM;

ACINETOBACTER BAUMANNII; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CITROBACTER FREUNDII; COAGULASE NEGATIVE STAPHYLOCOCCUS; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; IN VITRO STUDY; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MORGANELLA MORGANII; PRIORITY JOURNAL; PROTEUS MIRABILIS; PROVIDENCIA; SERRATIA MARCESCENS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

ANTI-BACTERIAL AGENTS; BACTERIA; CARBAPENEMS; CEPHALOSPORINS; DRUG THERAPY, COMBINATION; ENTEROBACTERIACEAE; GRAM-POSITIVE BACTERIA; MICROBIAL SENSITIVITY TESTS; PENICILLANIC ACID; PENICILLIN RESISTANCE; PENICILLINS; PIPERACILLIN;

EID: 1642420265     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.4.1384-1396.2004     Document Type: Article

References (12)

1. Iso, Y., T. Irie, Y. Nishino, K. Motokawa, and Y. Nishitani. 1996. A novel 1β-methylcarbapenem antibiotic, S-4661: synthesis and structure-activity relationships of 2-(5 substituted pyrrolidin-3-ylthio)-1β-methylcarbapenems. J. Antibiot. (Tokyo) 49:199-209.
2. Mori, M., M. Hikida, T. Nishihara, T. Nasu, and S. Mitsuhaski. 1996. Comparative stability of carbapenem and penem antibiotics to human recombinant dehydropeptidase-I. J. Antimicrob. Chemother. 37:1034-1036.
3. Murray, P. R., E. J. Baron, J. H. Jorgensen, M. A. Pfaller, and R. H. Yolken (ed.). 2003. Manual of clinical microbiology, 8th ed. ASM Press, Washington, D.C.
4. National Committee for Clinical Laboratory Standards. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 6th ed. Approved standard M7-A6. National Committee for Clinical Laboratory Standards, Wayne, Pa.
5. National Committee for Clinical Laboratory Standards. 2003. Performance standards for antimicrobial susceptibility testing; thirteenth informational supplement, vol. 23. M100-S13. National Committee for Clinical Laboratory Standards, Wayne, Pa.
6. Nomura, S., and A. Nagayama. 2002. In vitro antibacterial activity of S-4661, a new parenteral carbapenem, against urological pathogens isolated from patients with complicated urinary tract infections. J. Chemother. 14:155-160.
7. Ohiba, F., M. Nakamura-Kamigo, N. Watanabe, and K. Katsu. 1997. In vitro and in vivo antibacterial activities of ER-35786, a new antipseudomonal carbapenem. Antimicrob. Agents Chemother. 41:298-307.
8. Peterson, P. J., N. V. Jacobus, W. J. Weiss, and R. J. Testa. 1991. In vitro and in vivo activities of LJC10,627, a new carbapenem with stability to dehydropeptidase I. Antimicrob. Agents Chemother. 35:203-207.
9. Tsuji, M., Y. Ishii, A. Ohno, S. Miyazaki, and K. Yamaguchi. 1998. In vitro and in vivo antibacterial activities of S-4661, a new carbapenem. Antimicrob. Agents Chemother. 42:94-99.
10. Tsuji, M., H. Matsuda, H. Miwa, and S. Miyazaki. 2003. Antimicrobial-induced release of endotoxin from Pseudomonas aeruginosa: comparison of in vitro and animal models. J. Antimicrob. Chemother. 51:353-359.
11. Watanabe, A., H. Takahashi, T. Kikuchi, T. Kobayashi, K. Gomi, S. Fujimura, Y. Tokue, and T. Nukiwa. 2000. Comparative in vitro activity of S-4661, a new parenteral carbapenem, and other antimicrobial agents against respiratory pathogens. Chemotherapy 46:184-187.
12. Yamaguchi, K., H. Domon, S. Miyazaki, K. Tateda, A. Ohno, K. Ihii, T. Matsumoto, and N. Furuya. 1998. In vitro and in vivo antibacterial activities of CS-834, a new oral carbapenem. Antimicrob. Agents Chemother. 42:555-563.